Critical Life Science M&A Growth Strategies

Top life science M&A leaders share strategies to prevent financial pitfalls & bad partnerships

Meet with life science industry leaders for an exclusive strategy discussion on market expansion and value creation opportunities.

This is your chance to gain insider knowledge and make crucial connections that could define your company’s future.

CEO Strategy Roundtable is March 11th at 11a-12p EST.

$1B+ invested across 10 platform companies

Ashton Poole, Partner, QHP Capital

CEO of 6 global companies, 23 successful acquisitions

vitalink Website Headshots_Boyd Wainscott

Boyd Wainscott, M&A President

$20M+ EBITDA transformation expertise

vitalink Website Headshots_Jeanne Frazer

Jeanne Frazer, CEO, Forma Life Science

Partial List of Companies Our Leaders Have Worked With

Top 3 most valuable takeaways:

  • Gain insider knowledge and make crucial connections that could define your company’s future

  • Avoid common mistakes with first-hand insights from building and selling global companies, plus key criteria for acquisitions

  • Learn what makes your company irresistible to private equity firms and discover the perfect timing for PE engagement

Only 12 seats available for this exclusive session for C-Suite executives (no cost or obligation) involved in the M&A process for mid-market life science companies.

Reach out to our VP of Development, Rosanne Brouette, with questions: 415.416.4166 or rosanne@lifesciencemarketing.com